Spyre Therapeutics Inc. (SYRE) — Cash Flow Reinvestment Rate
Latest as of June 2021:
0.01x
Spyre Therapeutics Inc. (SYRE) has a Cash Flow Reinvestment Rate of 0.01x as of June 2021, reinvesting $30.00K (capex $30.00K ) from operating cash flow of $2.08 Million. Explore SYRE cash generation efficiency to assess how effectively this company generates cash.
Reinvestment Rate
0.01x
(Capex + Investments) / Operating CF
Total Reinvested
$30.00K
Capex + Investments
Operating Cash Flow
$2.08 Million
USD
Capital Expenditures
$30.00K
USD
Annual Cash Flow Reinvestment Rate for Spyre Therapeutics Inc. (None–None)
Year-by-year capital reinvestment analysis for Spyre Therapeutics Inc.. For live market cap and broader valuation context, see Spyre Therapeutics Inc. (SYRE) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow